News
PYPD
6.60
+4.60%
0.29
PolyPid Earnings Call Highlights D-PLEX100 Launch Path
TipRanks · 7h ago
PolyPid Highlights D-PLEX100 Regulatory Progress, Reports Narrower Q3 Loss; Stock Up
NASDAQ · 16h ago
PolyPid Q3 2026 Earnings Call Transcript
Benzinga · 17h ago
PolyPid reports Q3 results
Seeking Alpha · 19h ago
PolyPid Q3 EPS $(0.24) Misses $0.06 Estimate
Benzinga · 19h ago
PolyPid Nears a Potentially Transformative FDA Decision as It Advances Its Innovative Pipeline (NASDAQ: PYPD)
TipRanks · 1d ago
Weekly Report: what happened at PYPD last week (1102-1106)?
Weekly Report · 2d ago
PolyPid: Strong Phase 3 Data Support A Buy Ahead Of November's FDA Decision
Seeking Alpha · 11/04 08:44
Weekly Report: what happened at PYPD last week (1026-1030)?
Weekly Report · 11/02 09:50
This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Benzinga · 10/30 14:28
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
Benzinga · 10/29 18:32
Biotech Stocks Facing FDA Decision In November 2026
NASDAQ · 10/29 08:01
PolyPid Ltd. Introduces PD01B and Outlines D-PLEX₁₀₀ Milestones
NASDAQ · 10/28 17:59
This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Benzinga · 10/28 12:38
PolyPid Expands Kynatrix Pipeline With New PD01B Diabetic Foot Infection Candidate
TipRanks · 10/28 12:29
PolyPid spikes as Oppenheimer initiates at Outperform on lead asset
Seeking Alpha · 10/27 17:16
PolyPid rallies after Oppenheimer starts with Outperform rating
TipRanks · 10/27 14:45
This PPL Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga · 10/27 12:08
PolyPid Price Target Announced at $10.00/Share by Oppenheimer
Dow Jones · 10/27 11:02
Oppenheimer Initiates Coverage On PolyPid with Outperform Rating, Announces Price Target of $10
Benzinga · 10/27 10:52
More
Webull provides a variety of real-time PYPD stock news. You can receive the latest news about Polypid Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.